An Embryo Transfer Needs a Defined Uterine Question
Before an embryo is transferred, patients often ask whether the uterus has been “fully checked.”
The question is understandable. Embryos are limited and valuable, and a correctable problem inside the uterine cavity should not be ignored.
Yet no test can certify that a uterus will accept an embryo, and no procedure can guarantee implantation. A normal hysteroscopy does not prove that transfer will succeed. An unsuccessful transfer does not prove that a hidden lesion was missed.
The purpose of uterine-cavity assessment is narrower and more clinically useful: to identify structural findings that may change treatment, transfer timing, pregnancy planning, or surgical care.
At Jinemed, the decision is not “hysteroscopy for everyone” or “ultrasound is always enough.” It is to use the least invasive reliable method that answers the patient’s actual question—and to proceed to hysteroscopy when direct visualisation or treatment is justified.
Structure and Implantation Are Not the Same Thing
The uterine cavity is the space where an embryo implants. Polyps, submucosal fibroids, adhesions, congenital anomalies, and retained tissue may alter that space.
However, implantation also depends on embryo biology, endometrial preparation, hormonal timing, and factors that cannot be diagnosed simply by looking through a hysteroscope.
This distinction prevents two common errors:
- Assuming every implantation problem is caused by the cavity
- Assuming a normal cavity means that every other implantation factor is normal
Uterine evaluation should be integrated into the wider fertility assessment. It should not become a symbolic procedure performed to create certainty that medicine cannot provide.
The Clinical History Determines How Closely to Look
The need for cavity assessment is influenced by the patient’s history.
Relevant factors may include:
- Abnormal, heavy, or irregular uterine bleeding
- Bleeding between periods
- Infertility without a recent cavity assessment
- Recurrent pregnancy loss
- Previous uterine instrumentation or surgery
- Caesarean birth or retained pregnancy tissue
- Infection involving the uterus
- Reduced or absent menstrual flow after a uterine procedure
- A suspected polyp, fibroid, adhesion, or anomaly on imaging
- A difficult embryo transfer
- Several unsuccessful transfers in a clinically meaningful context
- An abnormal endometrial appearance during treatment
The absence of symptoms does not exclude a cavity finding. At the same time, an asymptomatic patient with recent, high-quality normal imaging may not benefit from repeating every available test.
The question should be individualised before the procedure is scheduled.
Transvaginal Ultrasound Is Usually the Starting Point
Transvaginal ultrasound provides information about the uterus, endometrial thickness and pattern, ovaries, fibroids, adenomyosis features, and some cavity lesions.
Its strengths include accessibility, lack of radiation, and the ability to combine uterine and ovarian assessment. Three-dimensional ultrasound can add coronal views that are particularly useful when uterine shape or a congenital anomaly is being considered.
Ultrasound also has limits. A small polyp may be difficult to distinguish from a fold in the endometrium. Adhesions may be subtle. The accuracy of the examination depends on timing within the menstrual cycle, image quality, and examiner experience.
A report that says “uterus normal” is less informative than one describing the endometrium, cavity contour, myometrium, and any focal lesion.
Ultrasound is not merely a screening step to be replaced automatically by hysteroscopy. In many patients, it provides enough information to proceed.
Saline Sonography Outlines the Cavity
Saline-infusion sonography—also called sonohysterography—uses a small amount of sterile fluid introduced through the cervix during ultrasound. The fluid separates the cavity walls and can make focal lesions easier to see.
It may help identify:
- Endometrial polyps
- Submucosal fibroids
- Intrauterine adhesions
- Irregular cavity contours
- Some congenital uterine findings
Saline sonography is less invasive than operative hysteroscopy and can provide useful mapping before treatment. It does not allow tissue removal or pathology diagnosis during the same procedure.
Timing, pregnancy exclusion, infection risk, cervical access, and patient comfort should be considered. If the result is clearly abnormal, hysteroscopy may then be planned as a therapeutic rather than purely diagnostic procedure.
Using imaging first can reduce unnecessary procedures while helping the surgeon prepare for those that are needed.
Hysterosalpingography Answers a Different Question
Hysterosalpingography, or HSG, uses contrast and X-ray imaging to assess the uterine cavity and whether contrast passes through the fallopian tubes.
It can reveal a possible filling defect or uterine anomaly, but it is not the most precise method for characterising every intracavitary lesion. It also cannot reliably distinguish a septate uterus from a bicornuate uterus because the external uterine contour is not shown adequately.
An HSG described as “abnormal cavity” often requires clarification with three-dimensional ultrasound, saline sonography, MRI in selected cases, or hysteroscopy.
For patients proceeding directly to IVF, tubal patency may not always be the main question, although hydrosalpinx and other tubal findings can still affect treatment.
One test should not be asked to answer a question it was not designed to resolve.
Hysteroscopy Provides Direct Visualisation
Hysteroscopy uses a thin camera passed through the cervix to view the uterine cavity directly. Diagnostic hysteroscopy assesses the cavity. Operative hysteroscopy allows treatment using instruments introduced through the hysteroscope.
It may be used to diagnose or treat:
- Endometrial polyps
- Submucosal fibroids
- Intrauterine adhesions
- Uterine septa
- Retained tissue
- Selected other focal abnormalities
The procedure can be performed in an office or operating-room setting depending on the expected treatment, instruments, cervical factors, pain management, and patient preference.
Direct vision is a major advantage, but hysteroscopy remains a medical procedure. Discomfort, bleeding, infection, cervical injury, uterine perforation, fluid-related complications, and adhesion formation are possible, with risk depending on the operation performed.
The ability to see the cavity does not make an unindicated procedure harmless or useful.
Routine Hysteroscopy Before Every IVF Cycle Is Not Evidence-Based
Some patients are offered hysteroscopy as a standard step before any embryo transfer, even when recent high-quality imaging is normal and there are no symptoms or relevant risk factors.
The evidence does not support treating routine hysteroscopy as a universal way to increase live birth.
Hysteroscopy may be reasonable when:
- Imaging suggests a lesion or anomaly
- The cavity has not been evaluated adequately
- Bleeding or menstrual changes create suspicion
- Previous uterine surgery or pregnancy-related instrumentation raises adhesion risk
- Transfer anatomy has been difficult
- A clinically meaningful pattern of unsuccessful transfers justifies reassessment
- Direct treatment is expected
After unsuccessful treatment, the threshold may change—but the procedure should still answer a defined question. “It might find something” is not the same as showing that every detected finding requires treatment or that treatment improves live birth.
An evidence-based centre should be able to explain why hysteroscopy is being recommended now.
Endometrial Polyps Need Context
Endometrial polyps are localised overgrowths of endometrial tissue. They may be associated with irregular bleeding, infertility, or no symptoms.
Ultrasound or saline sonography may suggest a polyp; hysteroscopy can confirm its location and allow removal. Tissue is generally sent for pathological examination according to clinical practice.
The reproductive importance of a polyp depends on factors such as:
- Size and location
- Whether it is persistent
- Symptoms
- Age and risk factors
- Whether natural conception, IUI, or embryo transfer is planned
- Available embryos and treatment timing
- Diagnostic certainty
Polypectomy may be considered before fertility treatment when a definite intracavitary polyp is likely to interfere with the planned pathway. However, evidence is not equally strong for every polyp size and every form of assisted reproduction.
A tiny suspected lesion on one scan should not automatically cancel treatment without confirmation. A clear focal lesion should not be ignored simply because it is asymptomatic.
Timing Polyp Removal Around IVF Requires a Sequence
A polyp discovered before ovarian stimulation may be removed first when the delay is acceptable and transfer is planned soon.
A polyp found during stimulation or after embryos have been created may lead to a different sequence:
- Complete egg collection when medically appropriate.
- Freeze embryos.
- Confirm and treat the cavity lesion.
- Allow appropriate recovery.
- Proceed to frozen embryo transfer.
This can protect reproductive time without transferring into a cavity that requires treatment.
The decision depends on the lesion, symptoms, age, ovarian reserve, cycle stage, and whether a fresh transfer was intended. Cancellation should be a clinical decision, not an automatic software rule.
Intrauterine Adhesions Can Reduce Functional Cavity Space
Intrauterine adhesions are bands of scar tissue that partially or extensively join the uterine walls. Severe symptomatic disease is often called Asherman syndrome.
Risk may increase after:
- Curettage or other uterine evacuation, particularly after pregnancy
- Retained placental or pregnancy tissue
- Postpartum procedures
- Uterine infection
- Myomectomy involving the cavity
- Septum surgery or other hysteroscopic treatment
- Repeated intrauterine instrumentation
Possible clues include lighter periods, absent menstruation, cyclical pain with reduced flow, infertility, recurrent loss, or abnormal imaging. Some patients have no obvious symptom.
Saline sonography may suggest adhesions, but hysteroscopy provides direct assessment and allows treatment.
Adhesions are not simply “scar tissue removed in one visit.” Their severity, location, remaining endometrium, recurrence risk, and effect on pregnancy vary widely.
Adhesiolysis Requires a Plan for Recurrence and Recovery
Hysteroscopic adhesiolysis aims to restore the cavity by dividing scar tissue under direct vision. Severe cases may require specialist expertise, image guidance, or staged procedures.
After treatment, clinicians may consider hormonal support, mechanical barriers, anti-adhesion products, or a second-look assessment in selected patients. Evidence for specific methods is variable, and no single postoperative protocol is appropriate for every case.
The follow-up plan should state:
- How cavity restoration will be assessed
- Whether further hysteroscopy or imaging is needed
- How menstruation changes after treatment
- When fertility treatment may resume
- What recurrence risk is expected
- Whether pregnancy will require additional obstetric attention
The goal is not only to divide visible adhesions. It is to determine whether a functional cavity and endometrial surface have been restored sufficiently for the next reproductive step.
Severe adhesions may carry a guarded prognosis even after technically successful surgery. Counselling should remain honest and individualised.
A Uterine Septum Must Be Diagnosed Correctly Before It Is Cut
A uterine septum is a congenital partition extending from the top of the uterine cavity to a variable degree. It is different from a bicornuate uterus, in which the external fundal contour is also divided.
This distinction is essential because hysteroscopy shows the inside of the uterus but not the complete external contour. Hysteroscopy alone cannot always distinguish between these anomalies.
Three-dimensional transvaginal ultrasound, with or without saline infusion, is recommended as a first-line non-invasive method for uterine-shape assessment. MRI or expert review may be useful when anatomy remains uncertain.
An arcuate contour is generally considered a normal variant rather than a septum requiring surgery.
Classification systems use measurements and angles, but borderline anatomy should not be treated as certainty simply because software produced a label.
The diagnosis should be established before hysteroscopic incision is proposed.
Septum Incision Is a Shared Decision in Infertility
Hysteroscopic septum incision divides septal tissue to create a more unified cavity. It does not require an abdominal incision.
The evidence differs according to the patient’s reproductive history.
For patients with recurrent miscarriage, septum incision may be offered through shared decision-making because evidence supports a possible reduction in loss and improvement in some obstetric outcomes.
For infertility or IVF without recurrent loss, the association between septum and infertility is less certain. Surgery is a reasonable option in selected patients, but current evidence does not prove that it increases live birth in every case.
Counselling should include:
- Diagnostic certainty
- Pregnancy and loss history
- Other infertility factors
- The limitations of the evidence
- Surgical risks
- The possibility that surgery may not improve live birth
- Expected healing and transfer timing
The size or shape of the septum alone does not reliably predict reproductive harm.
Shared decision-making means that uncertainty is part of the consent—not hidden from it.
Post-Septum Treatment Should Avoid Automatic Extra Procedures
After septum incision, the cavity heals over time. Fertility treatment can often resume after a limited recovery period based on operative findings and clinical guidance.
Routine use of oestrogen, intrauterine balloons, or intrauterine devices to prevent adhesions after septum surgery is not supported by strong evidence for every patient. Follow-up imaging or hysteroscopy may be considered when the operation was extensive, symptoms arise, or the surgeon needs to confirm healing.
A small residual septal area does not automatically require repeat surgery.
The postoperative plan should be proportionate to the procedure rather than built from a package of customary additions.
Hysteroscopy Cannot Diagnose Every Endometrial Problem by Appearance
Hysteroscopy can reveal polyps, adhesions, fibroids, abnormal vascularity, inflammation-like appearances, or irregular tissue. Visual impressions alone do not establish every microscopic diagnosis.
When chronic endometritis or another tissue-level condition is suspected, targeted or endometrial biopsy and appropriate pathological assessment may be required. Conversely, a visually “red” or “inflamed” cavity does not automatically justify antibiotics.
Routine biopsy, microbiome testing, immune testing, or receptivity testing should not be added simply because hysteroscopy was performed. Each test requires its own indication and evidence.
Structural evaluation and endometrial-function testing are related but not interchangeable.
The Timing of Hysteroscopy Matters
Diagnostic hysteroscopy is often scheduled when the endometrium is relatively thin and pregnancy has been excluded. Timing may improve visualisation and reduce the chance that early pregnancy is disrupted.
The exact plan depends on menstrual regularity, hormonal treatment, the procedure intended, infection risk, and anaesthetic or surgical requirements.
Patients should receive instructions about:
- Cycle timing and contraception or pregnancy avoidance where required
- Medication
- Pain relief or anaesthesia
- Eating and drinking restrictions if sedation is planned
- Expected bleeding and cramping
- Symptoms that require urgent review
- When intercourse, swimming, travel, or treatment can resume
- When pathology results will be available
An office procedure may allow rapid recovery, but “office” does not mean that consent and safety planning are optional.
A Normal Cavity Does Not Require Repeated Proof
Once the cavity has been assessed adequately and no new symptoms, procedures, or risk factors have appeared, repeating hysteroscopy before every transfer is unlikely to create better care.
Reassessment may become appropriate when:
- Substantial time has passed and clinical circumstances changed
- New bleeding or menstrual change occurs
- A pregnancy-related procedure or uterine surgery intervenes
- Imaging becomes abnormal
- A previous treatment was incomplete
- A meaningful pattern of failure changes the pre-test probability of pathology
The interval should not be determined by a universal expiry date printed on a package.
Good medicine avoids both neglect and ritual repetition.
Transfer Readiness Is a Decision, Not a Score
The decision to proceed with embryo transfer may include cavity structure, endometrial development, medication timing, embryo availability, general health, and patient consent.
No single uterine “fitness score,” Doppler cut-off, biopsy result, or hysteroscopy finding can validate implantation by itself.
A practical transfer-readiness decision asks:
- Has the cavity been assessed adequately for this patient?
- Is there a lesion that is likely to change the transfer outcome or pregnancy safety?
- If a finding exists, is treatment supported and complete?
- Has the cavity healed sufficiently after intervention?
- Are other clinical and embryological requirements ready?
- Does the patient understand the remaining uncertainty?
“No-go” should mean that a defined, relevant issue requires attention—not that an unvalidated metric failed to reach an arbitrary threshold.
International Patients Need Images, Not Only a Conclusion
Before travelling for embryo transfer or hysteroscopy, an international patient may be asked to provide:
- Recent transvaginal or three-dimensional ultrasound reports
- Original ultrasound or MRI images where possible
- Saline-sonography or HSG reports
- Previous hysteroscopy videos, images, and operative notes
- Pathology results
- Menstrual and bleeding history
- Details of pregnancy-related uterine procedures
- Previous embryo-transfer records
Remote review can determine whether the available assessment is sufficient, whether imaging should be repeated, or whether hysteroscopy is likely to be diagnostic or therapeutic.
A coordinator can organise the records. The decision must remain clinical.
Patients should not travel expecting a routine embryo transfer only to discover that a known cavity lesion requires treatment first. Equally, they should not be required to travel for an invasive procedure that recent reliable imaging does not justify.
Five Questions Before Hysteroscopy
At Jinemed, the indication can be tested through five questions:
- What specific cavity problem is suspected?
- Has a less invasive test already answered the question reliably?
- Will hysteroscopy diagnose, treat, or do both?
- Would the result change embryo-transfer timing or another part of care?
- What recovery or follow-up is required before treatment resumes?
If these questions cannot be answered, the procedure may be routine without being necessary.
If they can be answered clearly, hysteroscopy can be one of the most precise tools in reproductive surgery.
Evidence-Based Hysteroscopy Before Embryo Transfer
The uterine cavity deserves careful assessment before a valuable embryo is transferred. Careful does not mean maximal.
Polyps, adhesions, submucosal fibroids, septa, and retained tissue may require direct treatment. Three-dimensional ultrasound and saline sonography may define the problem without surgery. Hysteroscopy may then confirm and treat the finding under direct vision.
At Jinemed, evidence-based hysteroscopy means using the procedure for a reason that can be stated, documented, and connected to the next decision.
It also means knowing when not to perform it.
The goal is not to make every cavity look perfect according to an image. It is to identify clinically meaningful pathology, treat it proportionately, and proceed to embryo transfer without avoidable intervention or avoidable uncertainty.